Specimen Validity Testing Market Report
Covid-19 has impacted the market dynamics, competition, and global supply chains. The revenues has gone down in 2020 and may resume an uptrend gradually form 2021. Companies optimizing their operation and statergy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
This report, from Stratview Research, studies the specimen validity testing market over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
Specimen validity testing (SVT) is performed on a urine drug screen specimen to detect substitution, adulteration, or dilution. SVT includes assays for urinary pH, nitrates, oxidants, creatinine, specific gravity, and other indicators of specimen adulteration. In developed markets such as The United States the laboratories are only allowed to bill for screening and quantitative testing. There are instances where lab’s licenses have been revoked or suspended who have failed to comply with the above requirements.
Especially countries with border issues such as LATAM, US-Mexico, Eastern Russia, this test has higher significance to check the movements of drug peddlers. SVT is a major urine drug screening tool that can enhance border security (suspected cases i.e. detect drug – illicit and prescription), enhance workplace safety, monitor patients’ medication compliance, and abuse as well as prescription medication diversion. Because drug testing is associated with personal, occupational, and legal implications, pain specialists and primary care physicians must be confident in their abilities to interpret urine drug assay results in order to respond duly to optimize clinical outcomes.
Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
The global specimen validity testing market is segmented into the following categories:
With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].